查看購物車
  • English
  • Japanese
  • Korean
細胞療法CDMO市場規模及預測（2021-2031年），全球及區域佔有率、趨勢和成長機會分析報告：按服務類型、最終用戶和地區分類
市場調查報告書
商品編碼
1938295

細胞療法CDMO市場規模及預測（2021-2031年），全球及區域佔有率、趨勢和成長機會分析報告：按服務類型、最終用戶和地區分類

Cell Therapy CDMO Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 217 Pages | 訂單完成後即時交付

價格
細胞療法CDMO市場規模預計將從2024年的41.2億美元成長到2031年的219.2億美元，2025年至2031年的複合年成長率（CAGR）為27.1%。慢性病和罕見疾病的日益增多、生物技術和製藥公司對細胞療法生產的外包需求不斷成長，以及創新治療方法臨床試驗數量的增加，是推動細胞療法CDMO市場規模擴張的關鍵因素。此外，人工智慧和數位轉型的日益融合，以及先進自動化製造技術的廣泛應用，預計將在不久的將來為細胞療法CDMO市場帶來新的發展趨勢。

對大規模生產CAR-T細胞療法等治療方法的需求，正推動生產製造技術朝向先進的自動化方向發展。這一趨勢透過採用人工智慧、機器人和封閉式系統，降低了人工操作帶來的污染風險和變異性等挑戰。吉利德科學公司旗下的Kite Pharma公司就曾利用人工智慧驅動的製程最佳化、自動化細胞培養系統和封閉式生物反應器為Yescarta產品進行生產，結果表明，人工智慧和機器學習不僅可以最佳化生產參數，還能加強品管並預測結果。這些創新將生產流程從7到14天縮短至最短24小時，簡化了物流，並提高了病患的就醫便利性。

據AGC Biologics公司稱，自動化正在為自體療法的處理方式變革奠定基礎，其途徑包括減少人工操作步驟、將治療流程分散到不同機構以及利用人工智慧驅動的製程控制進行即時品質檢測。例如，Miltenyi Biotec公司的CliniMACS Prodigy和Lonza公司的Cocoon等工具，利用人工智慧分析技術在分散式生產中提高批次間的可重複性，而機器人技術則將人工接觸減少到傳統水平的10%以下，從而顯著縮短了人工操作時間。

這項技術的優勢包括提高效率、降低成本和提升質量，所有這些都得到了FDA和EMA的支持，它們強制要求業內使用封閉式系統。機器人和機器正在改變細胞治療合約開發和生產組織（CDMO）的格局，如今，它們能夠實現近乎完全的「無人值守」生產，並最大限度地減少人為干預。自動化生物反應器系統、封閉式工作流程和機器人技術不僅縮短了生產時間，也推動了CAR-T細胞當日處理能力的研究。這些技術的廣泛應用正在加速創新，而CDMO正憑藉其專業知識主導潮流，以滿足臨床試驗日益成長的需求。這正在成為細胞治療CDMO市場的關鍵趨勢。

最終用戶洞察

依最終用戶分類，細胞療法CDMO市場可分為製藥公司、生物製藥公司和其他最終用戶。截至2024年，生物製藥公司佔據了最大的市場。生物製藥公司，尤其是中小型創新企業，是細胞療法CDMO服務的主要使用者。雖然這些公司通常在新型細胞療法的早期發現和臨床開發中處於主導，但它們並非總是擁有符合GMP（良好生產規範）生產所需的高品質生產設施和監管知識。因此，它們會尋求CDMO的幫助，以克服這些障礙，並將科學創新轉化為潛在的臨床候選藥物。查爾斯河實驗室與蓋茲研究所就慢病毒載體CDMO達成的合作協議就是一個例證。該協議使生物製藥公司能夠專注於研究，同時利用CDMO在處理病毒載體和細胞加工等複雜流程方面的專業知識。

外包使生物製藥公司能夠加速研發進程，同時大幅降低資本投入和風險。此外，監管支持的加強和核准流程的簡化也是吸引生物製藥公司選擇CDMO的因素。 CDMO能夠幫助企業獲得最先進治療，而無需承擔內部生產帶來的經濟負擔。因此，與CDMO合作對於生物製藥產業從實驗室到臨床的順利快速轉化至關重要，這也推動了細胞療法CDMO市場的成長。

目錄

第1章執行摘要

  • 分析師市場展望
  • 市場吸引力

第2章 細胞療法CDMO市場概況

  • 價值鏈分析
  • 供應鏈分析
    • 製造商和供應商列表
    • 潛在客戶名單（最多 50 家公司）
  • PEST分析
  • 人工智慧（AI）的影響
  • 產品或技術藍圖
  • 永續性與ESG趨勢
  • 法律規範

第3章 競爭情勢

  • 主要企業進行企業標竿分析
  • 2024年主要企業市佔率分析
  • 市場集中度

4. 細胞療法CDMO市場－主要市場動態

  • 市場促進因素
    • 慢性病和罕見疾病日益增多的趨勢
    • 生物技術和製藥公司正在迅速將細胞療法生產外包。
    • 慢性病和罕見疾病日益增多的趨勢
  • 市場限制
    • 高昂的製造成本和營運成本
    • 製造過程的複雜性
    • 熟練勞動力短缺
  • 市場機遇
    • 向商業化規模生產過渡
    • 公司策略舉措
    • 地理和生產能力擴張
  • 未來趨勢
    • 人工智慧與數位轉型的日益融合
    • 先進自動化製造技術的日益普及
    • 基礎製造以外的專業化和附加價值服務
  • 促進因素和抑制因素的影響

5. 細胞療法CDMO市場－全球市場分析

  • 細胞療法CDMO市場收入，2021-2031年
  • 細胞療法CDMO市場預測與分析

6. 細胞療法CDMO市場按服務類型分類的收入分析

  • 細胞療法CDMO市場預測及服務類型分析
    • 藥物研發與生產
      • 藥物研發與生產：細胞療法CDMO市場－收入，2021-2031年
    • 測試和監管服務
      • 檢測與監管服務：細胞療法CDMO市場－收入，2021-2031年
    • 其他服務類型
      • 其他服務類型：細胞療法CDMO市場 - 收入，2021-2031年

7. 細胞療法CDMO市場按最終用戶分類的收入分析

  • 細胞療法CDMO市場預測及最終用戶分析
    • 製藥公司
      • 製藥公司：細胞療法CDMO市場－收入，2021-2031年
    • 生物製藥公司
      • 生物製藥公司：細胞療法CDMO市場－收入，2021-2031年
    • 其他最終用戶
      • 其他終端使用者：細胞療法CDMO市場－收入，2021-2031年

第8章 細胞療法CDMO市場—區域分析

  • 北美洲
    • 服務類型
    • 最終用戶
    • 美國市場
    • 加拿大市場
    • 墨西哥市場
  • 歐洲
    • 德國市場
    • 英國市場
    • 法國市場
    • 義大利市場
    • 西班牙市場
    • 其他歐洲市場
  • 亞太地區
    • 中國市場
    • 日本市場
    • 印度市場
    • 澳洲市場
    • 韓國市場
    • 亞太地區的其他國家
  • 中東和非洲市場
    • 沙烏地阿拉伯市場
    • 南非市場
    • 阿拉伯聯合大公國市場
    • 其他中東和非洲市場
  • 南美洲和中美洲
    • 巴西市場
    • 阿根廷市場
    • 其他南美洲和中美洲及其他區域市場

第9章：細胞療法CDMO市場產業概況

第10章 細胞療法CDMO市場－主要企業概況

  • WuXi Biologics Inc
  • Charles River Laboratories International Inc
  • Catalent Inc
  • Lonza Group AG
  • National Resilience Inc
  • Thermo Fisher Scientific Inc
  • AGC Biologics AS
  • Takara Bio Inc
  • FUJIFILM Holdings Corp
  • SK pharmteco Inc

第11章：待分析的其他公司名單

  • 待分析的其他公司名單

第12章附錄

Product Code: TIPRE00040637

The cell therapy CDMO market size is expected to grow from US$ 4.12 billion in 2024 to US$ 21.92 billion by 2031; it is projected to register a CAGR of 27.1% during 2025-2031. The increasing prevalence of chronic and rare diseases, surging outsourcing of cell therapy manufacturing by biotech and pharma companies, and expanding clinical trials for innovative therapies are noteworthy factors contributing to the expansion of the cell therapy CDMO market size. Additionally, the rising integration of AI and digital transformation, and increased adoption of advanced and automated manufacturing technologies are projected to bring new cell therapy CDMO market trends in the near future.

The requirement for the large-scale production of therapies like CAR-T cells is the main reason for the move toward advanced and automated manufacturing technologies. This trend alleviates the problems associated with manual processes, like the risk of contamination and variability, by incorporating AI, robotics, and closed systems. AI and machine learning not only optimize production parameters but also enhance quality control, and predict outcomes as evidenced by Kite Pharma's (Gilead Sciences) adoption of AI-driven process optimization, automated cell culture systems, and closed bioreactors for Yescarta. These breakthroughs cut the conventional timeframes of 7 to 14 days down to as little as 24 hours, thus simplifying logistics and improving patient access.

Per AGC Biologics, automation lays the foundation for the change in the way of handling autologous therapies by cutting back on the number of manual steps involved, allowing the splitting up of the treatment process across facilities, and even making use of AI-driven process controls for real-time quality testing. The CliniMACS Prodigy from Miltenyi Biotec and the Cocoon from Lonza are among the tools that facilitate batch reproducibility by employing AI analytics in decentralized manufacturing and also minimizing human contact through robotics to less than 10% of the conventional level, thus greatly reducing the hands-on time.

The benefits that accrue from this technology include increased efficiency, price reductions, and better quality, all of which are backed up by the FDA and EMA who make the use of closed systems mandatory for the industry. Robots and machines are changing the landscape of cell therapy contract development and manufacturing organizations (CDMOs) that now have the ability to do almost entirely "lights-off" manufacturing with very little human intervention. Automated bioreactor systems, closed workflows, and robotics are not only reducing manufacturing time but also conducting research in the area of same-day CAR-T processing capabilities. This increased adoption accelerates innovation and the CDMOs are the ones to lead it by using their specialized knowledge to meet the ever-increasing demand in clinical trials, thereby emerging as a significant trend in the cell therapy CDMO market.

End User-Based Insights

Based on end user, the cell therapy CDMO market is segmented into pharmaceutical companies, biopharmaceutical companies, and other end users. The biopharmaceutical companies segment held the largest cell therapy CDMO market share in 2024. Biopharmaceutical companies, and especially small and medium-sized innovators, are the main consumers of cell therapy CDMO services. These companies often take the initiative in the early discovery and clinical development of new cellular therapies, but they do not always possess the necessary high-quality manufacturing facility and regulatory know-how for the Good Manufacturing Practice (GMP) production. They resort to CDMOs for outsourcing which allows them to overcome this barrier thereby converting scientific innovation into potential clinical candidates. An example of such a collaboration is the agreement between Charles River Laboratories and the Gates Institute on lentiviral vector CDMO which enables biopharma companies to keep their focus on research while at the same time drawing on the CDMO's expertise in dealing with the intricate processes of viral vector and cell handling.

Through outsourcing, biopharma companies are able to minimize their capital expenditures and risks substantially while speeding up the development process. Besides that, the increasing regulatory support and the facilitation of the approval processes are among the factors that lure biopharma companies into the arms of CDMOs who would make the access to cutting-edge therapies possible without the financial burden of in-house production. Thus, partnerships with CDMOs are a must for the biopharmaceutical industry to smoothly and rapidly carry out the process from laboratory to clinic, thereby fueling the cell therapy CDMO market growth.

The World Health Organization and Australian Institute of Health and Welfare are among the primary and secondary sources referred to while preparing the cell therapy CDMO market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. Cell Therapy CDMO Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 PEST Analysis
  • 2.5 Impact of Artificial Intelligence (AI)
  • 2.6 Product or Technology Roadmap
  • 2.7 Sustainability and ESG Trends
  • 2.8 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2024 - By Key Players
  • 3.3 Market Concentration

4. Cell Therapy CDMO Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic and Rare Diseases
    • 4.1.2 Surging Outsourcing of Cell Therapy Manufacturing by Biotech and Pharma Companies
    • 4.1.3 Increasing Prevalence of Chronic and Rare Diseases
  • 4.2 Market Restraints
    • 4.2.1 High Manufacturing and Operational Costs
    • 4.2.2 Complexities in Manufacturing Processes
    • 4.2.3 Shortage of Skilled Workforce
  • 4.3 Market Opportunities
    • 4.3.1 Transition to Commercial-Scale Manufacturing
    • 4.3.2 Strategic Initiatives by Companies
    • 4.3.3 Geographic and Capacity Expansions
  • 4.4 Future Trends
    • 4.4.1 Rising Integration of AI and Digital Transformation
    • 4.4.2 Increased Adoption of Advanced & Automated Manufacturing Technologies
    • 4.4.3 Specialization & Value?Added Services Beyond Basic Manufacturing
  • 4.5 Impact of Drivers and Restraints

5. Cell Therapy CDMO Market - Global Market Analysis

  • 5.1 Cell Therapy CDMO Market Revenue (US$ Million), 2021-2031
  • 5.2 Cell Therapy CDMO Market Forecast and Analysis

6. Cell Therapy CDMO Market Revenue Analysis -Service Type

  • 6.1 Cell Therapy CDMO Market Forecasts and Analysis by Service Type
    • 6.1.1 Drug Development and Manufacturing
      • 6.1.1.1 Overview
      • 6.1.1.2 Drug Development and Manufacturing: Cell Therapy CDMO Market -Revenue, 2021-2031 (US$ Million)
    • 6.1.2 Testing and Regulatory Services
      • 6.1.2.1 Overview
      • 6.1.2.2 Testing and Regulatory Services: Cell Therapy CDMO Market -Revenue, 2021-2031 (US$ Million)
    • 6.1.3 Other Service Types
      • 6.1.3.1 Overview
      • 6.1.3.2 Other Service Types: Cell Therapy CDMO Market -Revenue, 2021-2031 (US$ Million)

7. Cell Therapy CDMO Market Revenue Analysis -End User

  • 7.1 Cell Therapy CDMO Market Forecasts and Analysis by End User
    • 7.1.1 Pharmaceutical Companies
      • 7.1.1.1 Overview
      • 7.1.1.2 Pharmaceutical Companies: Cell Therapy CDMO Market -Revenue, 2021-2031 (US$ Million)
    • 7.1.2 Biopharmaceutical Companies
      • 7.1.2.1 Overview
      • 7.1.2.2 Biopharmaceutical Companies: Cell Therapy CDMO Market -Revenue, 2021-2031 (US$ Million)
    • 7.1.3 Other End Users
      • 7.1.3.1 Overview
      • 7.1.3.2 Other End Users: Cell Therapy CDMO Market -Revenue, 2021-2031 (US$ Million)

8. Cell Therapy CDMO Market - Geographical Analysis

  • 8.1 North America
    • 8.1.1 North America Cell Therapy CDMO Market Overview
    • 8.1.2 North America: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 8.1.3 North America: Cell Therapy CDMO Market- By Segmentation
      • 8.1.3.1 Service Type
      • 8.1.3.2 End User
    • 8.1.4 North America: Cell Therapy CDMO Market Breakdown by Countries
      • 8.1.4.1 United States Market
        • 8.1.4.1.1 United States: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.1.4.1.2 United States: Cell Therapy CDMO Market- By Segmentation
          • 8.1.4.1.2.1 Service Type
          • 8.1.4.1.2.2 End User
      • 8.1.4.2 Canada Market
        • 8.1.4.2.1 Canada: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.1.4.2.2 Canada: Cell Therapy CDMO Market- By Segmentation
          • 8.1.4.2.2.1 Service Type
          • 8.1.4.2.2.2 End User
      • 8.1.4.3 Mexico Market
        • 8.1.4.3.1 Mexico: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.1.4.3.2 Mexico: Cell Therapy CDMO Market- By Segmentation
          • 8.1.4.3.2.1 Service Type
          • 8.1.4.3.2.2 End User
  • 8.2 Europe
    • 8.2.1 Europe Cell Therapy CDMO Market Overview
    • 8.2.2 Europe: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 8.2.3 Europe: Cell Therapy CDMO Market- By Segmentation
      • 8.2.3.1 Service Type
      • 8.2.3.2 End User
    • 8.2.4 Europe: Cell Therapy CDMO Market Breakdown by Countries
      • 8.2.4.1 Germany Market
        • 8.2.4.1.1 Germany: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.2.4.1.2 Germany: Cell Therapy CDMO Market- By Segmentation
          • 8.2.4.1.2.1 Service Type
          • 8.2.4.1.2.2 End User
      • 8.2.4.2 United Kingdom Market
        • 8.2.4.2.1 United Kingdom: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.2.4.2.2 United Kingdom: Cell Therapy CDMO Market- By Segmentation
          • 8.2.4.2.2.1 Service Type
          • 8.2.4.2.2.2 End User
      • 8.2.4.3 France Market
        • 8.2.4.3.1 France: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.2.4.3.2 France: Cell Therapy CDMO Market- By Segmentation
          • 8.2.4.3.2.1 Service Type
          • 8.2.4.3.2.2 End User
      • 8.2.4.4 Italy Market
        • 8.2.4.4.1 Italy: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.2.4.4.2 Italy: Cell Therapy CDMO Market- By Segmentation
          • 8.2.4.4.2.1 Service Type
          • 8.2.4.4.2.2 End User
      • 8.2.4.5 Spain Market
        • 8.2.4.5.1 Spain: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.2.4.5.2 Spain: Cell Therapy CDMO Market- By Segmentation
          • 8.2.4.5.2.1 Service Type
          • 8.2.4.5.2.2 End User
      • 8.2.4.6 Rest of Europe Market
        • 8.2.4.6.1 Rest of Europe: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.2.4.6.2 Rest of Europe: Cell Therapy CDMO Market- By Segmentation
          • 8.2.4.6.2.1 Service Type
          • 8.2.4.6.2.2 End User
  • 8.3 Asia Pacific
    • 8.3.1 Asia Pacific Cell Therapy CDMO Market Overview
    • 8.3.2 Asia Pacific: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 8.3.3 Asia Pacific: Cell Therapy CDMO Market- By Segmentation
      • 8.3.3.1 Service Type
      • 8.3.3.2 End User
    • 8.3.4 Asia Pacific: Cell Therapy CDMO Market Breakdown by Countries
      • 8.3.4.1 China Market
        • 8.3.4.1.1 China: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.3.4.1.2 China: Cell Therapy CDMO Market- By Segmentation
          • 8.3.4.1.2.1 Service Type
          • 8.3.4.1.2.2 End User
      • 8.3.4.2 Japan Market
        • 8.3.4.2.1 Japan: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.3.4.2.2 Japan: Cell Therapy CDMO Market- By Segmentation
          • 8.3.4.2.2.1 Service Type
          • 8.3.4.2.2.2 End User
      • 8.3.4.3 India Market
        • 8.3.4.3.1 India: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.3.4.3.2 India: Cell Therapy CDMO Market- By Segmentation
          • 8.3.4.3.2.1 Service Type
          • 8.3.4.3.2.2 End User
      • 8.3.4.4 Australia Market
        • 8.3.4.4.1 Australia: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.3.4.4.2 Australia: Cell Therapy CDMO Market- By Segmentation
          • 8.3.4.4.2.1 Service Type
          • 8.3.4.4.2.2 End User
      • 8.3.4.5 South Korea Market
        • 8.3.4.5.1 South Korea: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.3.4.5.2 South Korea: Cell Therapy CDMO Market- By Segmentation
          • 8.3.4.5.2.1 Service Type
          • 8.3.4.5.2.2 End User
      • 8.3.4.6 Rest of APAC Market
        • 8.3.4.6.1 Rest of APAC: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.3.4.6.2 Rest of APAC: Cell Therapy CDMO Market- By Segmentation
          • 8.3.4.6.2.1 Service Type
          • 8.3.4.6.2.2 End User
  • 8.4 Middle East and Africa
    • 8.4.1 Middle East and Africa Cell Therapy CDMO Market Overview
    • 8.4.2 Middle East and Africa: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 8.4.3 Middle East and Africa: Cell Therapy CDMO Market- By Segmentation
      • 8.4.3.1 Service Type
      • 8.4.3.2 End User
    • 8.4.4 Middle East and Africa: Cell Therapy CDMO Market Breakdown by Countries
      • 8.4.4.1 Saudi Arabia Market
        • 8.4.4.1.1 Saudi Arabia: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.4.4.1.2 Saudi Arabia: Cell Therapy CDMO Market- By Segmentation
          • 8.4.4.1.2.1 Service Type
          • 8.4.4.1.2.2 End User
      • 8.4.4.2 South Africa Market
        • 8.4.4.2.1 South Africa: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.4.4.2.2 South Africa: Cell Therapy CDMO Market- By Segmentation
          • 8.4.4.2.2.1 Service Type
          • 8.4.4.2.2.2 End User
      • 8.4.4.3 United Arab Emirates Market
        • 8.4.4.3.1 United Arab Emirates: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.4.4.3.2 United Arab Emirates: Cell Therapy CDMO Market- By Segmentation
          • 8.4.4.3.2.1 Service Type
          • 8.4.4.3.2.2 End User
      • 8.4.4.4 Rest of Middle East and Africa Market
        • 8.4.4.4.1 Rest of Middle East and Africa: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.4.4.4.2 Rest of Middle East and Africa: Cell Therapy CDMO Market- By Segmentation
          • 8.4.4.4.2.1 Service Type
          • 8.4.4.4.2.2 End User
  • 8.5 South and Central America
    • 8.5.1 South and Central America Cell Therapy CDMO Market Overview
    • 8.5.2 South and Central America: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
    • 8.5.3 South and Central America: Cell Therapy CDMO Market- By Segmentation
      • 8.5.3.1 Service Type
      • 8.5.3.2 End User
    • 8.5.4 South and Central America: Cell Therapy CDMO Market Breakdown by Countries
      • 8.5.4.1 Brazil Market
        • 8.5.4.1.1 Brazil: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.5.4.1.2 Brazil: Cell Therapy CDMO Market- By Segmentation
          • 8.5.4.1.2.1 Service Type
          • 8.5.4.1.2.2 End User
      • 8.5.4.2 Argentina Market
        • 8.5.4.2.1 Argentina: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.5.4.2.2 Argentina: Cell Therapy CDMO Market- By Segmentation
          • 8.5.4.2.2.1 Service Type
          • 8.5.4.2.2.2 End User
      • 8.5.4.3 Rest of South and Central America Market
        • 8.5.4.3.1 Rest of South and Central America: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
        • 8.5.4.3.2 Rest of South and Central America: Cell Therapy CDMO Market- By Segmentation
          • 8.5.4.3.2.1 Service Type
          • 8.5.4.3.2.2 End User

9. Cell Therapy CDMO Market Industry Landscape

10. Cell Therapy CDMO Market - Key Company Profiles

  • 10.1 WuXi Biologics Inc
    • 10.1.1 Key Facts
    • 10.1.2 Business Description
    • 10.1.3 Products and Services
    • 10.1.4 Financial Overview
    • 10.1.5 SWOT Analysis
    • 10.1.6 Key Developments
  • 10.2 Charles River Laboratories International Inc
    • 10.2.1 Key Facts
    • 10.2.2 Business Description
    • 10.2.3 Products and Services
    • 10.2.4 Financial Overview
    • 10.2.5 SWOT Analysis
    • 10.2.6 Key Developments
  • 10.3 Catalent Inc
    • 10.3.1 Key Facts
    • 10.3.2 Business Description
    • 10.3.3 Products and Services
    • 10.3.4 Financial Overview
    • 10.3.5 SWOT Analysis
    • 10.3.6 Key Developments
  • 10.4 Lonza Group AG
    • 10.4.1 Key Facts
    • 10.4.2 Business Description
    • 10.4.3 Products and Services
    • 10.4.4 Financial Overview
    • 10.4.5 SWOT Analysis
    • 10.4.6 Key Developments
  • 10.5 National Resilience Inc
    • 10.5.1 Key Facts
    • 10.5.2 Business Description
    • 10.5.3 Products and Services
    • 10.5.4 Financial Overview
    • 10.5.5 SWOT Analysis
    • 10.5.6 Key Developments
  • 10.6 Thermo Fisher Scientific Inc
    • 10.6.1 Key Facts
    • 10.6.2 Business Description
    • 10.6.3 Products and Services
    • 10.6.4 Financial Overview
    • 10.6.5 SWOT Analysis
    • 10.6.6 Key Developments
  • 10.7 AGC Biologics AS
    • 10.7.1 Key Facts
    • 10.7.2 Business Description
    • 10.7.3 Products and Services
    • 10.7.4 Financial Overview
    • 10.7.5 SWOT Analysis
    • 10.7.6 Key Developments
  • 10.8 Takara Bio Inc
    • 10.8.1 Key Facts
    • 10.8.2 Business Description
    • 10.8.3 Products and Services
    • 10.8.4 Financial Overview
    • 10.8.5 SWOT Analysis
    • 10.8.6 Key Developments
  • 10.9 FUJIFILM Holdings Corp
    • 10.9.1 Key Facts
    • 10.9.2 Business Description
    • 10.9.3 Products and Services
    • 10.9.4 Financial Overview
    • 10.9.5 SWOT Analysis
    • 10.9.6 Key Developments
  • 10.10 SK pharmteco Inc
    • 10.10.1 Key Facts
    • 10.10.2 Business Description
    • 10.10.3 Products and Services
    • 10.10.4 Financial Overview
    • 10.10.5 SWOT Analysis
    • 10.10.6 Key Developments

11. List of Additional Companies Analyzed

  • 11.1 List of Additional Companies Analyzed

12. Appendix

  • 12.1 Glossary
  • 12.2 Research Methodology and Approach
    • 12.2.1 Secondary Research
    • 12.2.2 Primary Research
    • 12.2.3 Market Estimation Approach
      • 12.2.3.1 Supply Side Analysis
      • 12.2.3.2 Demand Side Analysis
    • 12.2.4 Research Assumptions and Limitations
    • 12.2.5 Currency Conversion
  • 12.3 About The Insight Partners
  • 12.4 Market Intelligence Cloud

List Of Tables

  • Table 1. Cell Therapy CDMO Market Segmentation
  • Table 2. List of Regulatory Bodies and Organizations
  • Table 3. Ease of Doing Business: Key Country Rankings
  • Table 4. Market Share Analysis, 2024 - By Key Players
  • Table 5. Cell Therapy CDMO Market - Revenue, 2021-2024(US$ Million)
  • Table 6. Cell Therapy CDMO Market - Revenue Forecast, 2025-2031(US$ Million)
  • Table 7. Cell Therapy CDMO Market - Revenue, 2021-2024(US$ Million) - by Service Type
  • Table 8. Cell Therapy CDMO Market - Revenue Forecast, 2025-2031(US$ Million) - by Service Type
  • Table 9. Cell Therapy CDMO Market - Revenue, 2021-2024(US$ Million) - by End User
  • Table 10. Cell Therapy CDMO Market - Revenue Forecast, 2025-2031(US$ Million) - by End User
  • Table 11. North America: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 12. North America: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 13. North America: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 14. North America: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 15. North America: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 16. North America: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 17. United States: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 18. United States: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 19. United States: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 20. United States: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 21. Canada: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 22. Canada: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 23. Canada: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 24. Canada: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 25. Mexico: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 26. Mexico: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 27. Mexico: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 28. Mexico: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 29. Europe: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 30. Europe: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 31. Europe: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 32. Europe: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 33. Europe: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 34. Europe: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 35. Germany: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 36. Germany: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 37. Germany: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 38. Germany: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 39. United Kingdom: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 40. United Kingdom: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 41. United Kingdom: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 42. United Kingdom: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 43. France: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 44. France: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 45. France: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 46. France: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 47. Italy: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 48. Italy: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 49. Italy: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 50. Italy: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 51. Spain: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 52. Spain: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 53. Spain: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 54. Spain: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 55. Rest of Europe: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 56. Rest of Europe: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 57. Rest of Europe: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 58. Rest of Europe: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 59. Asia Pacific: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 60. Asia Pacific: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 61. Asia Pacific: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 62. Asia Pacific: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 63. Asia Pacific: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 64. Asia Pacific: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 65. China: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 66. China: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 67. China: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 68. China: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 69. Japan: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 70. Japan: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 71. Japan: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 72. Japan: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 73. India: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 74. India: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 75. India: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 76. India: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 77. Australia: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 78. Australia: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 79. Australia: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 80. Australia: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 81. South Korea: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 82. South Korea: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 83. South Korea: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 84. South Korea: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 85. Rest of APAC: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 86. Rest of APAC: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 87. Rest of APAC: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 88. Rest of APAC: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 89. Middle East and Africa: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 90. Middle East and Africa: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 91. Middle East and Africa: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 92. Middle East and Africa: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 93. Middle East and Africa: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 94. Middle East and Africa: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 95. Saudi Arabia: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 96. Saudi Arabia: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 97. Saudi Arabia: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 98. Saudi Arabia: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 99. South Africa: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 100. South Africa: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 101. South Africa: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 102. South Africa: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 103. United Arab Emirates: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 104. United Arab Emirates: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 105. United Arab Emirates: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 106. United Arab Emirates: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 107. Rest of Middle East and Africa: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 108. Rest of Middle East and Africa: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 109. Rest of Middle East and Africa: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 110. Rest of Middle East and Africa: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 111. South and Central America: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 112. South and Central America: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 113. South and Central America: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 114. South and Central America: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 115. South and Central America: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Country
  • Table 116. South and Central America: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Country
  • Table 117. Brazil: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 118. Brazil: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 119. Brazil: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 120. Brazil: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 121. Argentina: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 122. Argentina: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 123. Argentina: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 124. Argentina: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 125. Rest of South and Central America: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by Service Type
  • Table 126. Rest of South and Central America: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by Service Type
  • Table 127. Rest of South and Central America: Cell Therapy CDMO Market - Revenue, 2021-2024 (US$ Million) - by End User
  • Table 128. Rest of South and Central America: Cell Therapy CDMO Market - Revenue Forecast, 2025-2031 (US$ Million) - by End User
  • Table 129. List of Additional Companies Analyzed
  • Table 130. Glossary - Cell Therapy CDMO Market

List Of Figures

  • Figure 1. Cell Therapy CDMO Market - Value Chain Analysis
  • Figure 2. Pest Analysis
  • Figure 3. Cell Therapy CDMO Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. Cell Therapy CDMO Market Revenue (US$ Million), 2021-2031
  • Figure 6. Cell Therapy CDMO Market Share (%) - by Service Type (2024 and 2031)
  • Figure 7. Drug Development and Manufacturing: Cell Therapy CDMO Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 8. Testing and Regulatory Services: Cell Therapy CDMO Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 9. Other Service Types: Cell Therapy CDMO Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 10. Cell Therapy CDMO Market Share (%) - by End User (2024 and 2031)
  • Figure 11. Pharmaceutical Companies: Cell Therapy CDMO Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 12. Biopharmaceutical Companies: Cell Therapy CDMO Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 13. Other End Users: Cell Therapy CDMO Market -Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 14. Cell Therapy CDMO Market Breakdown by Geography, 2024 and 2031
  • Figure 15. North America: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 16. North America: Cell Therapy CDMO Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 17. United States: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 18. Canada: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 19. Mexico: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 20. Europe: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 21. Europe: Cell Therapy CDMO Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 22. Germany: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 23. United Kingdom: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 24. France: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 25. Italy: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 26. Spain: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 27. Rest of Europe: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 28. Asia Pacific: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 29. Asia Pacific: Cell Therapy CDMO Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 30. China: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 31. Japan: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 32. India: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 33. Australia: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 34. South Korea: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 35. Rest of APAC: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 36. Middle East and Africa: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 37. Middle East and Africa: Cell Therapy CDMO Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 38. Saudi Arabia: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 39. South Africa: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 40. United Arab Emirates: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 41. Rest of Middle East and Africa: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 42. South and Central America: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 43. South and Central America: Cell Therapy CDMO Market Breakdown by Key Countries, 2024 and 2031 (%)
  • Figure 44. Brazil: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 45. Argentina: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 46. Rest of South and Central America: Cell Therapy CDMO Market Revenue and Forecasts, 2021-2031 (US$ Million)
  • Figure 47. Bottom-Up Approach and Top-Down Approach